# Project Roadmap and Implementation Plan

**Project:** Infectious Disease Diagnosis Clinical Decision Support System
**Date:** 2025-11-15
**Version:** 1.0
**Planning Horizon:** 12-18 months

---

## Executive Summary

This roadmap outlines the development plan for the Infectious Disease Diagnosis Clinical Decision Support System over 6 phases spanning approximately 12-18 months. The project combines predictive machine learning models with LLM-powered conversational AI to assist clinicians in infectious disease diagnosis.

**Key Milestones:**
- Month 3: Pilot predictive model ready
- Month 6: Basic RAG chatbot functional
- Month 9: Integrated system prototype
- Month 12: Clinical validation complete
- Month 15-18: Production deployment

---

## Development Phases

### Phase 1: Research & Planning ✓ COMPLETED

**Timeline:** Month 1 (November 2025)
**Status:** ✓ Complete

**Objectives:**
- [x] Define project requirements and scope
- [x] Conduct methodology research
- [x] Design system architecture
- [x] Analyze market and competitive landscape
- [x] Evaluate data sources

**Deliverables:**
- [x] Project README.md
- [x] CURRENT_STATUS.md
- [x] Market Analysis document
- [x] Methodology Review document
- [x] Data Source Analysis
- [x] System Architecture document
- [x] Requirements Specification
- [x] Project Roadmap (this document)

**Key Decisions Made:**
- Dual-component system: Predictive Model + LLM Chatbot
- Data sources: StatPearls, Medscape, PubMed
- Technology stack: Python, XGBoost/CatBoost, RAG with GPT-4/Claude
- Target users: Infectious disease clinicians

---

### Phase 2: Data Collection & Preparation

**Timeline:** Months 2-3 (December 2025 - January 2026)
**Duration:** 8-10 weeks
**Status:** Planned

#### Objectives

**Legal and Partnerships:**
- Secure data access agreements for StatPearls and Medscape
- Review terms of service and licensing requirements
- Establish partnerships or licensing if needed
- Legal review of data extraction methods

**Data Acquisition:**
- Extract medical content from approved sources
- Collect open medical literature (PubMed, CDC, WHO)
- Acquire or synthesize training data for predictive model
- Document all data sources and provenance

**Data Processing:**
- Clean and structure medical content
- Create knowledge base for RAG system
- Prepare training datasets for ML model
- Implement data quality checks

**Knowledge Base Construction:**
- Convert medical content to appropriate formats
- Generate embeddings with BioBERT/PubMedBERT
- Populate vector database
- Create metadata and indexing structure

#### Deliverables

- [ ] Data licensing agreements secured
- [ ] 5,000+ disease/pathogen documents in knowledge base
- [ ] Training dataset with 1,000+ synthetic/real cases
- [ ] Data processing pipeline documented
- [ ] Vector database populated and tested
- [ ] Data quality report

#### Success Criteria

- Legal clearance for primary data sources
- Minimum 5,000 infectious disease documents
- Knowledge base retrieval accuracy >80%
- Training data covers 50+ common infectious diseases

#### Risks and Mitigation

| Risk | Mitigation |
|------|------------|
| Data access denied | Pivot to open sources (PubMed, CDC), delay timeline |
| Insufficient training data | Generate synthetic data, partner with institutions |
| Data quality issues | Implement validation, expert review |

---

### Phase 3: Predictive Model Development

**Timeline:** Months 3-5 (January 2026 - March 2026)
**Duration:** 10-12 weeks
**Status:** Planned

#### Objectives

**Model Development:**
- Implement feature engineering pipeline
- Develop baseline models (XGBoost, CatBoost, Random Forest)
- Train ensemble model
- Implement explainability (SHAP)

**Model Evaluation:**
- Cross-validation on training data
- Evaluation on hold-out test set
- Calibration of probability outputs
- Clinical validation with expert review

**Model Optimization:**
- Hyperparameter tuning
- Feature selection optimization
- Ensemble weight optimization
- Performance benchmarking

**Deployment Preparation:**
- Create model serving API (FastAPI)
- Containerize model service (Docker)
- Implement monitoring and logging
- Version control and MLflow integration

#### Deliverables

- [ ] Feature engineering pipeline
- [ ] Trained ensemble model (XGBoost + CatBoost + RF)
- [ ] SHAP explainability integration
- [ ] Model evaluation report (accuracy, calibration, etc.)
- [ ] Model serving API
- [ ] Docker container for model service
- [ ] Model documentation

#### Success Criteria

- Top-3 accuracy ≥ 75% on validation set
- Well-calibrated probabilities (Brier score)
- Response time < 2 seconds
- Explainability metrics available
- Passing expert clinical review (sample cases)

#### Key Tasks

**Week 1-2:**
- Set up development environment
- Implement data loading and preprocessing
- Develop feature engineering pipeline

**Week 3-5:**
- Train baseline models (XGBoost, CatBoost, RF)
- Initial evaluation and hyperparameter tuning
- Cross-validation experiments

**Week 6-8:**
- Develop ensemble model
- Implement SHAP explainability
- Calibration and optimization

**Week 9-10:**
- Create model serving API
- Containerization and deployment prep
- Expert clinical review

**Week 11-12:**
- Bug fixes and refinements
- Documentation
- Testing and validation

---

### Phase 4: LLM Chatbot Development

**Timeline:** Months 4-6 (February 2026 - April 2026)
**Duration:** 10-12 weeks
**Status:** Planned
**(Overlaps with Phase 3)**

#### Objectives

**RAG Implementation:**
- Set up vector database (ChromaDB for dev, Pinecone for prod)
- Implement embedding generation (BioBERT/PubMedBERT)
- Develop retrieval pipeline with re-ranking
- Integrate LLM (GPT-4 or Claude)

**Chatbot Development:**
- Design conversation flow
- Implement prompt engineering for clinical context
- Develop response generation with source attribution
- Create safety constraints and guardrails

**Integration with Knowledge Base:**
- Connect to populated vector database
- Optimize retrieval strategy
- Implement hybrid search (semantic + keyword)
- Test retrieval quality

**Testing and Refinement:**
- Test chatbot responses for accuracy
- Evaluate hallucination rates
- Expert review of clinical recommendations
- Iterate on prompts and retrieval

#### Deliverables

- [ ] RAG pipeline implemented (embedding, retrieval, generation)
- [ ] Vector database integration
- [ ] Chatbot API (FastAPI)
- [ ] Prompt templates for clinical scenarios
- [ ] Source attribution system
- [ ] Chatbot evaluation report
- [ ] Docker container for chatbot service

#### Success Criteria

- Factual accuracy > 95%
- Hallucination rate < 5%
- Response time < 5 seconds
- 100% source attribution for clinical claims
- Passing expert clinical review

#### Key Tasks

**Week 1-3:**
- Set up vector database
- Implement embedding generation
- Develop basic retrieval pipeline

**Week 4-6:**
- Integrate LLM (GPT-4 or Claude)
- Implement re-ranking for retrieval
- Develop prompt engineering framework

**Week 7-9:**
- Build chatbot API
- Implement conversation management
- Develop source attribution system

**Week 10-12:**
- Testing and evaluation
- Expert review and refinement
- Documentation

---

### Phase 5: Integration & Testing

**Timeline:** Months 7-9 (May 2026 - July 2026)
**Duration:** 10-12 weeks
**Status:** Planned

#### Objectives

**System Integration:**
- Integrate predictive model with chatbot
- Develop conversation manager/orchestrator
- Implement unified API
- Create end-to-end workflows

**User Interface Development:**
- Design web UI mockups
- Implement responsive web interface
- Develop chat interface components
- Create prediction visualization components

**Testing:**
- Integration testing of all components
- End-to-end testing of workflows
- Load testing and performance optimization
- Security testing and HIPAA compliance review

**Clinical Validation:**
- Prepare validation study protocol
- Recruit infectious disease specialists
- Conduct expert evaluation (100+ test cases)
- Analyze validation results

#### Deliverables

- [ ] Integrated system (predictive model + chatbot)
- [ ] Conversation manager/orchestrator
- [ ] Web-based user interface
- [ ] Integration test suite
- [ ] Load testing results
- [ ] Security audit report
- [ ] Clinical validation study results
- [ ] User documentation

#### Success Criteria

- All components integrated seamlessly
- End-to-end workflows functional
- System handles 100+ concurrent users
- Security and HIPAA compliance verified
- Clinical validation shows clinical utility
- System Usability Scale (SUS) score > 70

#### Key Tasks

**Week 1-3:**
- Develop integration layer
- Connect predictive model and chatbot
- Implement conversation manager

**Week 4-6:**
- Design and implement web UI
- Develop chat interface
- Create visualization components

**Week 7-9:**
- Integration and E2E testing
- Load and performance testing
- Security audit

**Week 10-12:**
- Clinical validation study
- Bug fixes and refinements
- Documentation and user guides

---

### Phase 6: Deployment & Iteration

**Timeline:** Months 10-18 (August 2026 - March 2027)
**Duration:** 6-9 months
**Status:** Planned

#### Objectives

**Pilot Deployment:**
- Deploy to staging environment
- Onboard 3-5 pilot clinics
- Collect real-world usage data
- Gather clinician feedback

**Production Deployment:**
- Set up production infrastructure (AWS/GCP/Azure HIPAA)
- Deploy to production environment
- Implement monitoring and alerting
- Establish support processes

**Iterative Improvement:**
- Analyze usage patterns and feedback
- Refine model and chatbot based on real-world data
- Update knowledge base regularly
- Optimize performance

**Expansion:**
- Expand to additional clinics
- Develop marketing and outreach materials
- Establish partnerships
- Plan for scale-up

#### Deliverables

- [ ] Staging environment deployment
- [ ] Production environment deployment
- [ ] Pilot program with 3-5 clinics
- [ ] Real-world usage analytics
- [ ] User feedback reports
- [ ] Iterative improvement plan
- [ ] Expansion strategy

#### Success Criteria

- 3-5 pilot clinics onboarded
- 50+ active users
- 99% uptime in production
- Positive clinician feedback (satisfaction >4/5)
- Clinical utility demonstrated (time savings, diagnostic accuracy)
- Path to broader adoption established

#### Key Tasks

**Months 10-11 (Pilot Phase):**
- Deploy to staging environment
- Onboard pilot clinics
- Training and support for pilot users
- Collect usage data and feedback

**Month 12 (Production Prep):**
- Set up production infrastructure
- Security and compliance final review
- Production deployment
- Monitoring and alerting setup

**Months 13-15 (Early Production):**
- Support pilot users
- Gather feedback and iterate
- Update models and knowledge base
- Performance optimization

**Months 16-18 (Expansion):**
- Expand to additional clinics
- Marketing and outreach
- Partnership development
- Plan next phase of development

---

## Resource Requirements

### Personnel

**Phase 1-2 (Months 1-3):**
- Project Lead (1 FTE)
- ML Engineer (0.5 FTE)
- Data Engineer (0.5 FTE)
- Medical Advisor (0.25 FTE - consultant)

**Phase 3-4 (Months 3-6):**
- Project Lead (1 FTE)
- ML Engineer (1 FTE)
- AI/LLM Engineer (1 FTE)
- Data Engineer (0.5 FTE)
- Medical Advisor (0.25 FTE)

**Phase 5 (Months 7-9):**
- Project Lead (1 FTE)
- ML Engineer (0.5 FTE)
- AI/LLM Engineer (0.5 FTE)
- Full-Stack Developer (1 FTE)
- QA Engineer (0.5 FTE)
- Medical Advisor (0.5 FTE - for validation)

**Phase 6 (Months 10-18):**
- Project Lead (1 FTE)
- DevOps Engineer (1 FTE)
- Support Engineer (0.5 FTE)
- Medical Advisor (0.25 FTE)

### Infrastructure

**Development (Months 1-6):**
- Development laptops/workstations
- Cloud development environment (AWS/GCP free tier or small instances)
- Version control (GitHub)
- Local vector database (ChromaDB)

**Testing & Staging (Months 7-9):**
- Staging environment (cloud instances)
- Vector database (managed service)
- Testing tools and automation

**Production (Months 10+):**
- HIPAA-compliant cloud infrastructure (AWS/GCP/Azure)
- Managed vector database (Pinecone or equivalent)
- Monitoring and logging infrastructure (Prometheus, Grafana, ELK)
- Load balancers and auto-scaling
- Backup and disaster recovery

### External Services

- **LLM API:** GPT-4 or Claude (API subscription)
- **Vector Database:** Pinecone or managed alternative
- **Cloud Infrastructure:** AWS/GCP/Azure with HIPAA BAA
- **Data Sources:** StatPearls and Medscape licensing (if applicable)

---

## Budget Estimate (Rough)

### Development Phase (Months 1-9)

**Personnel:** $300K - $500K
- Project Lead, engineers, consultants

**Infrastructure:** $5K - $10K
- Development and staging environments
- Tools and software licenses

**Data & Services:** $10K - $30K
- LLM API costs (development and testing)
- Data licensing (if applicable)
- Vector database services

**Total Development:** $315K - $540K

### Deployment & Initial Production (Months 10-18)

**Personnel:** $200K - $350K
- Reduced team, support staff

**Infrastructure:** $30K - $60K
- Production cloud infrastructure
- Scaling for user growth

**Services:** $20K - $50K
- LLM API costs (production usage)
- Vector database production tier
- Monitoring and support tools

**Total Deployment:** $250K - $460K

**Grand Total (18 months):** $565K - $1M

*Note: Budget is rough estimate. Actual costs depend on team location, cloud usage, LLM API volume, etc.*

---

## Risk Management

### High-Priority Risks

| Risk | Probability | Impact | Mitigation |
|------|------------|--------|------------|
| Data access denied for StatPearls/Medscape | Medium | High | Pivot to open sources, budget delay |
| Model accuracy below target | Medium | High | Iterative improvement, more data, expert input |
| LLM hallucinations persist | Medium | Critical | Strong RAG, validation, confidence scoring |
| Regulatory/FDA classification issues | Low | Critical | Legal review early, position as decision support |
| HIPAA compliance failure | Low | Critical | Early compliance audit, expert consultation |
| Pilot clinics decline to participate | Medium | Medium | Identify multiple candidates, value proposition |

### Ongoing Risk Monitoring

- Weekly risk review during development
- Monthly risk assessment meetings
- Risk register maintained and updated
- Escalation process for critical risks

---

## Success Metrics and KPIs

### Development Phase Metrics

**Phase 2:**
- Data collection: 5,000+ documents
- Data quality: >90% accuracy in extraction

**Phase 3:**
- Model accuracy: Top-3 ≥75%, target 85%
- Model response time: <2 seconds

**Phase 4:**
- Chatbot factual accuracy: >95%
- Hallucination rate: <5%
- Response time: <5 seconds

**Phase 5:**
- Integration testing: 100% pass rate
- Load testing: 100+ concurrent users
- SUS score: >70

### Production Phase Metrics

**System Performance:**
- Uptime: 99%+
- Response time: <5 seconds (95th percentile)
- Error rate: <1%

**User Adoption:**
- Active users: 50+ (month 12), 200+ (month 18)
- Daily active users: 30%+
- Retention: 80%+ month-over-month

**Clinical Utility:**
- Time to diagnosis: Reduced by 20%+ (measured in pilot)
- Diagnostic test ordering: More appropriate (expert review)
- Clinician confidence: Improved (survey)
- Clinician satisfaction: >4/5

**Business Metrics:**
- Number of clinics: 5+ (pilot), 20+ (month 18)
- Revenue (if applicable): Target based on pricing model
- Customer acquisition cost: Within budget
- Path to profitability: Defined and on track

---

## Dependencies and Assumptions

### Critical Dependencies

1. **Data Access:** StatPearls and Medscape content availability
2. **LLM API:** GPT-4 or Claude API reliability and cost stability
3. **Cloud Infrastructure:** HIPAA-compliant cloud provider availability
4. **Expert Reviewers:** Access to infectious disease specialists for validation
5. **Pilot Partners:** Willingness of clinics to participate in pilot

### Key Assumptions

1. **Technology:** LLM and ML technologies continue to improve and remain accessible
2. **Regulatory:** System can be positioned as decision support (not FDA Class II/III device)
3. **Market:** Clinicians are receptive to AI-powered decision support tools
4. **Resources:** Budget and personnel availability as outlined
5. **Timeline:** No major regulatory or legal obstacles cause extended delays

---

## Communication and Reporting

### Stakeholder Updates

**Weekly:**
- Development team standup/sync
- Progress updates to project lead

**Bi-weekly:**
- Project status report to stakeholders
- Risk and issue review

**Monthly:**
- Comprehensive progress report
- Budget and timeline review
- Stakeholder meeting

**Milestone-based:**
- Phase completion reviews
- Go/no-go decisions for next phases

### Documentation

- **Technical Documentation:** Maintained throughout development
- **User Documentation:** Developed in Phase 5
- **Clinical Validation Reports:** Published after Phase 5
- **Project Retrospectives:** After each phase

---

## Next Steps (Immediate)

Following completion of Phase 1 (Research & Planning), immediate next steps:

1. **Legal Review:**
   - Engage legal counsel for data licensing review
   - Review terms of service for StatPearls and Medscape
   - Prepare partnership outreach materials

2. **Data Source Outreach:**
   - Contact StatPearls for research partnership inquiry
   - Contact Medscape/WebMD for content licensing
   - Explore NCBI Bookshelf StatPearls availability

3. **Team Formation:**
   - Recruit or assign ML Engineer
   - Recruit or assign AI/LLM Engineer
   - Recruit or assign Data Engineer
   - Engage medical advisor (infectious disease specialist)

4. **Infrastructure Setup:**
   - Set up development environment
   - Create GitHub repository
   - Set up cloud development accounts (AWS/GCP/Azure)
   - Establish CI/CD pipeline foundation

5. **Phase 2 Kickoff:**
   - Hold Phase 2 kickoff meeting
   - Assign tasks and responsibilities
   - Establish development cadence (sprints, standups, etc.)
   - Begin data collection and preparation work

---

## Conclusion

This roadmap provides a comprehensive 12-18 month plan to develop, validate, and deploy the Infectious Disease Diagnosis Clinical Decision Support System. The phased approach allows for iterative development, clinical validation, and risk mitigation.

**Key Success Factors:**
- Strong technical execution across ML and LLM components
- Clinical validation and expert involvement throughout
- Careful attention to regulatory and liability considerations
- User-centered design for clinician workflow integration
- Iterative improvement based on real-world feedback

**Next Major Milestone:** Completion of Phase 2 (Data Collection & Preparation) by end of Month 3

---

**Document Status:** v1.0 - Initial Planning
**Next Review:** End of Phase 2 (Month 3)
**Owner:** Project Lead
